JP Morgan Rates CME Overweight, $367 Price Target

JP Morgan upgraded its rating on CME Group Inc. (NASDAQ:CME) to Overweight on October 22, 2026, setting a price target of $367.00. The research note outlines a bullish forward-looking view for the financial exchange operator as markets navigate shifting interest rates and global trading volumes. CME Group closed at $306.73 on the day of the announcement.

CME CME Group Inc.

$295.79 ▲ +13.42% year to date

1M 3M YTD

Daily close · Oct 21, 2026

JP Morgan's Call on CME Group

In its October 22 research note, JP Morgan assigned an Overweight rating to CME Group alongside a price target of $367.00. The firm did not have a recorded prior target for the stock. This optimistic call highlights confidence in the exchange operator's core business model of running global trading markets for futures and options.

Other Institutional Activity in CME Group

Large financial institutions continue to manage substantial stakes in the exchange operator. Sanders Capital, LLC grew its holdings by 906,692 shares, ending its reported period with 5,067,740 shares worth about $1.55 billion.

CME Group Inc. Stock Up 0.8%

CME Group shares recently traded around $295.79 as of October 22, 2026, sitting below the session's close of $306.73. The stock trades above its 50-day moving average of $274.96 and its 200-day moving average of $278.92. The company carries a market capitalization of $106.19 billion and a price-to-earnings ratio of 25.05.

Recent Earnings

CME Group reported trailing twelve-month revenue of $6.76 billion and earnings of $11.79 per share. The company achieved a net profit margin of 63.4% and a return on equity of 15.8%.

Dividend

CME Group pays an annual dividend rate of $5.20 per share, giving it a dividend yield of 1.76% with a payout ratio of 95.4%.

Insider Buying and Selling at CME Group Inc.

Company insiders have been active in the stock over recent months. Director William R. Shepard bought 339 shares on June 25, 2026, at an average price of $230.57 for a total value of $78,186. Later, Chief Executive Officer Terrence A. Duffy sold 15,000 shares on September 10, 2026, for a total value of $4,116,539. Director Elizabeth A. Cook sold 500 shares on September 14, 2026, at an average price of $280.11 for a total value of $140,055. Finally, Director William R. Shepard bought another 292 shares on September 25, 2026, at an average price of $268.76 for a total value of $78,626.

Analysts Set New Price Targets

Other Wall Street firms adjusted their views on the stock around the same period. On October 14, 2026, Wells Fargo maintained its Overweight rating and raised its target from $301.00 to $315.00. On October 22, 2026, Barclays maintained an Equal-Weight rating while lifting its target from $281.00 to $321.00. On that same day, Wells Fargo raised its target further to $333.00 with an Overweight rating, and Piper Sandler reiterated its Overweight rating with a target increase from $295.00 to $330.00. Consensus analyst data shows a hold recommendation across 16 opinions with a mean price target of $292.94.

About CME Group

Based in Chicago, Illinois, CME Group operates global contract markets for trading futures and options. The company provides venues to trade products tied to interest rates, equity indexes, foreign exchange, agricultural goods, energy, and metals.

Bottom Line

JP Morgan's new Overweight rating reflects positive expectations for the exchange operator. Investors will monitor trading volumes and upcoming financial reports to see if the company meets these heightened market expectations.